BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
PPARA
,
Fatty acid metabolic process
,
Arthritis
,
Neuron
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
protein serine/threonine/tyrosine kinase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bronchus
Skeletal muscle
Colon cecum
Pericardium
Adipose tissue
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Poisoning by drug AND/OR medicinal substance
Pyloric ulcer
Toxic nephropathy
Alpha-1-antitrypsin deficiency
Barrett's esophagus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
GSK-1059615
CGP 60474
A 443654
AZD1480
OTS-167
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCDH11X
DIDO1
FUBP3
NR5A1
PCDH11X
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Dendritic cells infected with M. tuberculosis
PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
microRNA expression in human hepatitis C virus (HCV) postitive livers
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for protein serine/threonine/tyrosine kinase activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple…
Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Perio…
The Effect of the Preoperative Oral Carbohydrate Attenuating Immediate Postoperative Insulin Resista…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ